Annual SGA
$17.58 M
-$2.09 M-10.64%
December 31, 2023
Summary
- As of February 7, 2025, PRQR annual SGA is $17.58 million, with the most recent change of -$2.09 million (-10.64%) on December 31, 2023.
- During the last 3 years, PRQR annual SGA has risen by +$1.95 million (+12.47%).
- PRQR annual SGA is now -14.46% below its all-time high of $20.55 million, reached on December 31, 2021.
Performance
PRQR SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$3.61 M
+$366.50 K+11.30%
September 1, 2024
Summary
- As of February 7, 2025, PRQR quarterly SGA is $3.61 million, with the most recent change of +$366.50 thousand (+11.30%) on September 1, 2024.
- Over the past year, PRQR quarterly SGA has increased by +$1400.00 (+0.04%).
- PRQR quarterly SGA is now -40.61% below its all-time high of $6.08 million, reached on December 31, 2021.
Performance
PRQR Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$1.79 B
-$48.01 M-2.75%
September 1, 2024
Summary
- As of February 7, 2025, PRQR TTM SGA is -$1.79 billion, with the most recent change of -$48.01 million (-2.75%) on September 1, 2024.
- Over the past year, PRQR TTM SGA has dropped by -$1.81 billion (-11659.79%).
- PRQR TTM SGA is now -35228.37% below its all-time high of -$5.07 million.
Performance
PRQR TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
PRQR Selling, General & Administrative Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -10.6% | +0.0% | -10000.0% |
3 y3 years | +12.5% | -33.1% | -7971.8% |
5 y5 years | +18.7% | -33.1% | -7971.8% |
PRQR Selling, General & Administrative Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -14.5% | at low | -40.6% | +18.8% | -153.1% | at low |
5 y | 5-year | -14.5% | +21.8% | -40.6% | +18.8% | -169.3% | at low |
alltime | all time | -14.5% | +1583.8% | -40.6% | +1289.8% | <-9999.0% | at low |
ProQR Therapeutics NV Selling, General & Administrative Expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $3.61 M(+11.3%) | $15.72 M(+0.0%) |
Jun 2024 | - | $3.24 M(-13.5%) | $15.72 M(-7.5%) |
Mar 2024 | - | $3.75 M(-26.7%) | $16.99 M(-3.3%) |
Dec 2023 | $17.58 M(-10.6%) | $5.12 M(+41.7%) | $17.57 M(+13.4%) |
Sep 2023 | - | $3.61 M(-20.1%) | $15.49 M(-10.4%) |
Jun 2023 | - | $4.52 M(+4.5%) | $17.28 M(-6.7%) |
Mar 2023 | - | $4.32 M(+42.3%) | $18.53 M(-6.0%) |
Dec 2022 | $19.67 M(-4.3%) | $3.04 M(-43.7%) | $19.71 M(-13.4%) |
Sep 2022 | - | $5.40 M(-6.4%) | $22.75 M(-0.1%) |
Jun 2022 | - | $5.76 M(+4.7%) | $22.77 M(+3.6%) |
Mar 2022 | - | $5.51 M(-9.4%) | $21.97 M(+7.2%) |
Dec 2021 | $20.55 M(+31.5%) | $6.08 M(+12.3%) | $20.48 M(+10.2%) |
Sep 2021 | - | $5.41 M(+9.0%) | $18.59 M(+12.9%) |
Jun 2021 | - | $4.97 M(+23.5%) | $16.46 M(+7.7%) |
Mar 2021 | - | $4.02 M(-3.9%) | $15.29 M(-1.9%) |
Dec 2020 | $15.63 M(+8.3%) | $4.19 M(+27.5%) | $15.59 M(-1.0%) |
Sep 2020 | - | $3.28 M(-13.4%) | $15.74 M(+0.4%) |
Jun 2020 | - | $3.80 M(-12.2%) | $15.68 M(+3.7%) |
Mar 2020 | - | $4.32 M(-0.3%) | $15.12 M(+4.8%) |
Dec 2019 | $14.43 M | $4.34 M(+34.4%) | $14.42 M(-6.2%) |
Sep 2019 | - | $3.23 M(-0.1%) | $15.38 M(+1.5%) |
Jun 2019 | - | $3.23 M(-10.9%) | $15.15 M(+0.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2019 | - | $3.62 M(-31.5%) | $15.08 M(+2.3%) |
Dec 2018 | $14.81 M(+20.6%) | $5.29 M(+76.5%) | $14.74 M(+14.7%) |
Sep 2018 | - | $3.00 M(-5.2%) | $12.85 M(-1.8%) |
Jun 2018 | - | $3.16 M(-3.6%) | $13.09 M(-0.1%) |
Mar 2018 | - | $3.28 M(-3.6%) | $13.11 M(+6.7%) |
Dec 2017 | $12.28 M(+17.0%) | $3.40 M(+5.2%) | $12.28 M(+8.5%) |
Sep 2017 | - | $3.24 M(+1.7%) | $11.31 M(+9.7%) |
Jun 2017 | - | $3.18 M(+29.6%) | $10.31 M(+2.3%) |
Mar 2017 | - | $2.45 M(+0.7%) | $10.08 M(-4.0%) |
Dec 2016 | $10.49 M(+38.3%) | $2.44 M(+9.2%) | $10.50 M(+2.4%) |
Sep 2016 | - | $2.23 M(-24.4%) | $10.25 M(+6.4%) |
Jun 2016 | - | $2.95 M(+2.9%) | $9.63 M(+11.5%) |
Mar 2016 | - | $2.87 M(+31.2%) | $8.64 M(+14.0%) |
Dec 2015 | $7.59 M(-12.3%) | $2.19 M(+35.0%) | $7.58 M(-3.9%) |
Sep 2015 | - | $1.62 M(-17.5%) | $7.89 M(-16.3%) |
Jun 2015 | - | $1.96 M(+8.6%) | $9.42 M(-1.5%) |
Mar 2015 | - | $1.81 M(-27.5%) | $9.56 M(+11.6%) |
Dec 2014 | $8.65 M(+728.9%) | $2.49 M(-20.9%) | $8.57 M(+30.9%) |
Sep 2014 | - | $3.15 M(+49.8%) | $6.55 M(+79.3%) |
Jun 2014 | - | $2.11 M(+158.3%) | $3.65 M(+136.2%) |
Mar 2014 | - | $815.20 K(+73.1%) | $1.55 M(+111.5%) |
Dec 2013 | $1.04 M | $471.00 K(+81.3%) | $730.80 K(+181.3%) |
Sep 2013 | - | $259.80 K | $259.80 K |
FAQ
- What is ProQR Therapeutics NV annual SGA?
- What is the all time high annual SGA for ProQR Therapeutics NV?
- What is ProQR Therapeutics NV annual SGA year-on-year change?
- What is ProQR Therapeutics NV quarterly SGA?
- What is the all time high quarterly SGA for ProQR Therapeutics NV?
- What is ProQR Therapeutics NV quarterly SGA year-on-year change?
- What is ProQR Therapeutics NV TTM SGA?
- What is the all time high TTM SGA for ProQR Therapeutics NV?
- What is ProQR Therapeutics NV TTM SGA year-on-year change?
What is ProQR Therapeutics NV annual SGA?
The current annual SGA of PRQR is $17.58 M
What is the all time high annual SGA for ProQR Therapeutics NV?
ProQR Therapeutics NV all-time high annual SGA is $20.55 M
What is ProQR Therapeutics NV annual SGA year-on-year change?
Over the past year, PRQR annual SGA has changed by -$2.09 M (-10.64%)
What is ProQR Therapeutics NV quarterly SGA?
The current quarterly SGA of PRQR is $3.61 M
What is the all time high quarterly SGA for ProQR Therapeutics NV?
ProQR Therapeutics NV all-time high quarterly SGA is $6.08 M
What is ProQR Therapeutics NV quarterly SGA year-on-year change?
Over the past year, PRQR quarterly SGA has changed by +$1400.00 (+0.04%)
What is ProQR Therapeutics NV TTM SGA?
The current TTM SGA of PRQR is -$1.79 B
What is the all time high TTM SGA for ProQR Therapeutics NV?
ProQR Therapeutics NV all-time high TTM SGA is -$5.07 M
What is ProQR Therapeutics NV TTM SGA year-on-year change?
Over the past year, PRQR TTM SGA has changed by -$1.81 B (-11659.79%)